NEW YORK (GenomeWeb News) - Entelos said today that UCB Pharma will use its PhysioLab biosimulation platform for rheumatoid arthritis research.
 
The Rheumatoid Arthritis PhysioLab is a predictive computer model that simulates arthritic patients and drug effects.
 
The company said that researchers use the system to select targets and compounds, find the best doses for patients, and support clinical trial design.
 
Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.